Tarr Mark J 4
4 · Encompass Health Corp · Filed May 20, 2025
Insider Transaction Report
Form 4
Tarr Mark J
DirectorPresident & CEO
Transactions
- Exercise/Conversion
Encompass Health Common Stock
2025-05-20$35.06/sh+56,306$1,974,088→ 583,376 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-05-20−62,078→ 0 totalExercise: $44.67From: 2019-03-01Exp: 2028-03-01→ Encompass Health Common Stock (62,078 underlying) - Sale
Encompass Health Common Stock
2025-05-20$120.94/sh−94$11,368→ 645,360 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
2025-05-20−56,306→ 0 totalExercise: $35.06From: 2018-02-24Exp: 2027-02-24→ Encompass Health Common Stock (56,306 underlying) - Exercise/Conversion
Encompass Health Common Stock
2025-05-20$44.67/sh+62,078$2,773,024→ 645,454 total - Sale
Encompass Health Common Stock
2025-05-20$121.53/sh−118,290$14,375,784→ 527,070 total
Footnotes (2)
- [F1]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.03 to $121.96, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
- [F2]The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.